Cargando…

Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells

[Image: see text] As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is still ongoing and dramatically influences our life, the need for recombinant viral proteins for diagnostics, vaccine development, and research is very high. The spike (S) protein, and particularly its r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gstöttner, Christoph, Zhang, Tao, Resemann, Anja, Ruben, Sophia, Pengelley, Stuart, Suckau, Detlev, Welsink, Tim, Wuhrer, Manfred, Domínguez-Vega, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078197/ https://www.ncbi.nlm.nih.gov/pubmed/33871970 http://dx.doi.org/10.1021/acs.analchem.1c00893

Ejemplares similares

Rapid, automated characterization of disulfide bond scrambling and IgG2 isoform determination
por: Resemann, Anja, et al.
Publicado: (2018)

Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner
por: Gstöttner, Christoph, et al.
Publicado: (2022)

Full validation of therapeutic antibody sequences by middle-up mass measurements and middle-down protein sequencing
por: Resemann, Anja, et al.
Publicado: (2016)

Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques
por: Ayoub, Daniel, et al.
Publicado: (2013)

Top-Down Identification and Sequence Analysis of Small Membrane Proteins Using MALDI-MS/MS
por: Meier-Credo, Jakob, et al.
Publicado: (2022)

Affinity Capillary Electrophoresis–Mass Spectrometry as a Tool to Unravel Proteoform-Specific Antibody–Receptor Interactions
por: Gstöttner, Christoph, et al.
Publicado: (2021)

Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
por: Möginger, Uwe, et al.
Publicado: (2016)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein
por: Fan, Youpeng, et al.
Publicado: (2022)

The Art of Destruction: Optimizing Collision Energies in Quadrupole-Time of Flight (Q-TOF) Instruments for Glycopeptide-Based Glycoproteomics
por: Hinneburg, Hannes, et al.
Publicado: (2016)

Native Structural and Functional Proteoform Characterization of the Prolyl-Alanyl-Specific Endoprotease EndoPro from Aspergillus niger
por: van Schaick, Guusje, et al.
Publicado: (2021)

Antibodies Produced Toward Recombinant RBD and Nucleocapsid Neutralize SARS-COV-2
por: Rezaei, Amir, et al.
Publicado: (2022)

INVect - a novel polycationic reagent for transient transfection of mammalian cells
por: Püngel, Sebastian, et al.
Publicado: (2013)

Media on‐demand: Continuous reconstitution of a chemically defined media directly from solids
por: Komuczki, Daniel, et al.
Publicado: (2021)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

A Multi-Disulfide Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike Protein Expressed in E. coli Using a SEP-Tag Produces Antisera Interacting with the Mammalian Cell Expressed Spike (S1) Protein
por: Brindha, Subbaian, et al.
Publicado: (2022)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein
por: Vetráková, A., et al.
Publicado: (2023)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis
por: Vergoossen, Dana L. E., et al.
Publicado: (2021)

Characterization and prediction of positional 4-hydroxyproline and sulfotyrosine, two post-translational modifications that can occur at substantial levels in CHO cells-expressed biotherapeutics
por: Tyshchuk, Oksana, et al.
Publicado: (2019)

Reversed Phase-Liquid Chromatography for Recombinant AAV Genome Integrity Assessment
por: Gstöttner, Christoph, et al.
Publicado: (2023)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study)
por: Hajizadeh, Faezeh, et al.
Publicado: (2022)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants
por: Wu, Yan, et al.
Publicado: (2023)

Recombinant Protein Expression and Purification of N, S1, and RBD of SARS-CoV-2 from Mammalian Cells and Their Potential Applications
por: García-Cordero, Julio, et al.
Publicado: (2021)

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
por: Lin, Ting-Wei, et al.
Publicado: (2022)

Structurally unique interaction of RBD-like and PH domains is crucial for yeast pheromone signaling
por: Yerko, Volodymyr, et al.
Publicado: (2013)

Software-Assisted Data Processing Workflow for Intact Glycoprotein Mass Spectrometry
por: Moran, Alan B., et al.
Publicado: (2023)

Antisera Produced Using an E. coli-Expressed SARS-CoV-2 RBD and Complemented with a Minimal Dose of Mammalian-Cell-Expressed S1 Subunit of the Spike Protein Exhibits Improved Neutralization
por: Yoshizue, Takahiro, et al.
Publicado: (2023)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
por: Sanyal, Dwipanjan, et al.
Publicado: (2022)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022)

Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
por: Otsubo, Ryota, et al.
Publicado: (2022)

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
por: Omotuyi, Olaposi, et al.
Publicado: (2023)

Mathematical expeditions: chronicles by the explorers
por: Laubenbacher, Reinhard, et al.
Publicado: (1999)

Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry
por: Gstöttner, Christoph, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ve6v7momn7op9sbrs8vf8bp7d8